PathDrugomics
San Francisco
About PathDrugomics
PathDrugomics exponentially increases the efficiency of drug discovery and disrupts the billion dollar per compound cost of bringing a new therapeutic into the market. Our products utilize the speed of accelerating computational technologies and the intelligence of big data analytics to model interactions between newly discovered drugs and their possible targets within diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $28.0K
- Funding stage: Seed
- Last round: Seed (Jul 2013)
- Website: pathdrugomics.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Clinical Trials, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/pathdrugomics-2919194 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.